Ability of two commercially available assays (Abbott RealTime HIV-1 and Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Version 2.0) to quantify low HIV-1 RNA Levels (<1,000 copies/milliliter): comparison with clinical samples and NIBSC working reagent for
about
Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort StudyTransient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study.Comparison of Three Different FDA-Approved Plasma HIV-1 RNA Assay Platforms Confirms the Virologic Failure Endpoint of 200 Copies per Milliliter Despite Improved Assay Sensitivity.Evaluation of the RealTime HIV-1, Xpert HIV-1, and Aptima HIV-1 Quant Dx Assays in Comparison to the NucliSens EasyQ HIV-1 v2.0 Assay for Quantification of HIV-1 Viral Load.Evaluation of Performance Characteristics of the Aptima HIV-1 Quant Dx Assay for Detection and Quantitation of Human Immunodeficiency Virus Type 1 in Plasma and Cervicovaginal Lavage Samples.Evaluation of the Aptima HIV-1 Quant Dx Assay Using Plasma and Dried Blood SpotsSensitivity and specificity of dried blood spots for HIV-1 viral load quantification: A laboratory assessment of 3 commercial assaysEvaluation of the Aptima(®) HIV-1 Quant Dx assay for HIV-1 RNA viral load detection and quantitation in plasma of HIV-1-infected individuals: A comparison with Abbott RealTime HIV-1 assay.Performance characteristics of finger-stick dried blood spots (DBS) on the determination of human immunodeficiency virus (HIV) treatment failure in a pediatric population in Mozambique.European Multicenter Study on Analytical Performance of Veris HIV-1 Assay.
P2860
Q28550940-5AC511A0-3C29-4E09-BC7D-75002304C1A3Q35782774-B28673A7-D193-4C11-B821-DE9DACC65D60Q35868687-310C122B-B4EA-4317-A9DF-D939F13F48F3Q36173963-DDB50A92-B9FD-4A57-BB35-ACCF94862237Q36734872-4480614D-EB5A-43DE-AB0E-CA4044F8C24BQ37280615-F9704465-CD4A-4690-B7F8-726D6915AC88Q39336961-0A0F6101-3FE6-4B03-BB77-CD84BAA33EC9Q40007100-3E391FDC-97A6-4264-A12C-1D85CAF97205Q40124082-311C6904-A4FC-4655-B8B7-0E13BBFB013BQ40235669-00E94940-6BD6-4A50-912E-93E286BACD86
P2860
Ability of two commercially available assays (Abbott RealTime HIV-1 and Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Version 2.0) to quantify low HIV-1 RNA Levels (<1,000 copies/milliliter): comparison with clinical samples and NIBSC working reagent for
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Ability of two commercially av ...... and NIBSC working reagent for
@ast
Ability of two commercially av ...... and NIBSC working reagent for
@en
type
label
Ability of two commercially av ...... and NIBSC working reagent for
@ast
Ability of two commercially av ...... and NIBSC working reagent for
@en
prefLabel
Ability of two commercially av ...... and NIBSC working reagent for
@ast
Ability of two commercially av ...... and NIBSC working reagent for
@en
P2093
P2860
P50
P356
P1476
Ability of two commercially av ...... and NIBSC working reagent for
@en
P2093
Claudio Angeletti
Maria Bloisi
Patrizia Marsella
P2860
P304
P356
10.1128/JCM.00288-14
P407
P577
2014-03-26T00:00:00Z